Evolution AB (publ)
F:E3G1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Evolution AB (publ)
F:E3G1
|
SE |
|
Al-Dawaa Medical Services Co
SAU:4163
|
SA |
Wall St Price Targets
E3G1 Price Targets Summary
Evolution AB (publ)
According to Wall Street analysts, the average 1-year price target for E3G1 is 63.43 EUR with a low forecast of 47.3 EUR and a high forecast of 107.57 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is E3G1's stock price target?
Price Target
63.43
EUR
According to Wall Street analysts, the average 1-year price target for E3G1 is 63.43 EUR with a low forecast of 47.3 EUR and a high forecast of 107.57 EUR.
What is the Revenue forecast for Evolution AB (publ)?
Projected CAGR
5%
Over the last 12 years, the compound annual growth rate for Revenue has been 40%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for Evolution AB (publ)?
Projected CAGR
4%
Over the last 12 years, the compound annual growth rate for Operating Income has been 51%. The projected CAGR for the next 3 years is 4%.
What is the Net Income forecast for Evolution AB (publ)?
Projected CAGR
8%
Over the last 12 years, the compound annual growth rate for Net Income has been 52%. The projected CAGR for the next 3 years is 8%.
